Strikingly, 26% of participants on the highest dose of retatrutide (12 mg) lost more than 30% of their body weight. Losing and maintaining weight loss of more than 10% is associated with significantly reducing complications related to obesity, including hypertension, type 2 diabetes, and heart disease.

